Oral immunotherapies in MS a comparison of efficacy.


Manage episode 231337390 series 1426075
By Discovered by Player FM and our community — copyright is owned by the publisher, not Player FM, and audio streamed directly from their servers.
Associate Professor Tomas Kalincik (University of Melbourne, Australia) discusses oral immunotherapies, and what we know about the effects of these treatments on patient relapse and disability. Read the full paper here: https://jnnp.bmj.com/content/early/2019/01/12/jnnp-2018-319831

2479 episodes available. A new episode about every 22 hours averaging 20 mins duration .